Patient survey regarding pathological re-examination in the course of chemotherapy for advanced and recurrent non-small cell lung cancer

Patient survey regarding pathological re-examination in the course of chemotherapy for advanced and recurrent non-small cell lung cancer - Questionnaire survey on re-biopsy in non-small cell lung cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018538

Enrollment

100

Registered

2015-08-04

Start date

2015-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Pathologically confirmed non-small lung cancer 2) Advanced and recurrent non-small cell lung cancer (stage III or IV) 3) Make plan to do chemotherapy 4) Obtain written consent from patient

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Patient survey to give consent for pathological re-examination in treatment course of non-small cell lung cancer	—

Countries

Japan

Contacts

Public ContactTomoya Fukui

Kitasato University School of Medicine Department of Respiratory Medicine

kokyuki@kitasato-u.ac.jp042-778-8111

Outcome results